Jarvik 2015 (15mm VAD)
Pediatric Severe Heart Failure (Bridge-to-Transplant)
Clinical TrialActive
Key Facts
Indication
Pediatric Severe Heart Failure (Bridge-to-Transplant)
Phase
Clinical Trial
Status
Active
Company
About Jarvik Heart
Jarvik Heart is a pioneering developer of miniaturized ventricular assist devices, founded by renowned inventor Dr. Robert Jarvik. The company's core technology focuses on continuous-flow heart pumps, with its Jarvik 2000 device approved for bridge-to-transplant and lifetime use in several international markets and under investigation in the U.S. Its key innovation is the Jarvik 2015, a VAD the size of a AA battery, which is the subject of pediatric clinical trials (PumpKIN) and represents a significant advancement in treating smaller patients and enabling less invasive surgery. The company remains private, with a lean operational model centered on R&D and manufacturing in Manhattan.
View full company profile